Eric Benevich — Chief Commercial Officer at Neurocrine Biosciences

Mr. Eric S. Benevich has been the Chief Commercial Officer at Neurocrine Biosciences Inc. since May 26, 2015. Mr. Benevich has over twenty years of previous experience in the pharmaceutical industry with Peninsula Pharmaceuticals, Amgen and AstraZeneca in the sales and marketing of drugs such as Enbrel??, Epogen?? and Prilosec??. served as Vice President of Marketing at Avanir Pharmaceuticals. since august 2007, where he was responsible for NUEDEXTA?? and commercialization of their CNS pipeline. Mr. Benevich served as Vice President of Communications of Avanir Pharmaceuticals since August 2007. Mr. Benevich served as Senior Director, Marketing of Avanir Pharmaceuticals since July 2005. Mr. Benevich served as Senior Director of Marketing at Peninsula Pharmaceuticals. Since October 2006, he served as the Executive Director of Marketing at Avanir Pharmaceuticals. Previously, Mr. Benevich was the Senior Director of Marketing at Peninsula Pharmaceuticals leading all pre-launch activities to support the launch of two antibiotics into the hospital market. Mr. Benevich also has experience in other commercial areas such as sales, market research, Amgen Inc. His extensive launch and brand management experience on products such as Prilosec, Epogen and Enbrel is especially beneficial to AVANIR as it plans for the launch of its Neurodex product. Mr. Benevich has BBA in International Business from Washington State University and has completed several MBA courses at Villanova University.